Long-term Efficacy and Safety of Tozorakimab in Participants With Chronic Obstructive Pulmonary Disease With a History of Exacerbations (PROSPERO).

NCT05742802 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

1713

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

COMBINATION_PRODUCT: Tozorakimab 1
COMBINATION_PRODUCT: Tozorakimab 2
COMBINATION_PRODUCT: Placebo

Sponsor

AstraZeneca